Prolyl hydroxylase inhibitor treatment confers whole‐animal hypoxia tolerance
Authors:
- 5 April 2007
- journal article
- Published by Wiley in Acta Physiologica
- Vol. 190 (2) , 163-169
Abstract
Aim: Recently a family of O2‐dependent prolyl hydroxylase domain‐containing enzymes (PHD) has been identified as a cellular oxygen‐sensing mechanism. Reduced prolyl hydroxylase activity initiates a signalling cascade that includes the accumulation, as well as the activation, of hypoxia‐inducible factor (HIF‐1α). In turn the transcription factor HIF‐1α, and other targets of the PHD, elicit a myriad of incompletely understood cellular responses. In these studies we have tested: (1) whether a small‐molecule prolyl hydroxylase inhibitor (PHI) can effectively activate the oxygen‐sensing pathway when administered systemically to mice, and (2) whether the activation of the PHD signalling pathway at the cellular level results in whole‐animal hypoxic tolerance.Methods: Mice received daily injections of the PHI, ethyl‐3,4 dihydroxybenzoate (EDHB, 100–250 mg kg−1) or vehicle. Tissue levels of HIF‐1α and the serum levels of the HIF‐inducible gene, erythropoietin (EPO), were measured to evaluate PHD‐pathway activation. To evaluate hypoxic tolerance, the endurance and survival ability of these animals was tested in sublethal (8% O2) and lethal hypoxia (5% O2) respectively.Results: Systemic treatment of mice with the PHD inhibitor, EDHB, leads to elevated levels of HIF‐1α in liver and HIF‐inducible EPO in serum, indicating activation of the cellular oxygen‐sensing pathway. Animals treated with EDHB display significantly increased viability and enhanced exercise performance in hypoxia.Conclusion: These results demonstrate a novel pharmacological strategy to induce hypoxic tolerance and are the first to demonstrate that the activation of the PHD oxygen‐sensing pathway at the cellular level is sufficient to produce a hypoxic‐tolerant phenotype at the physiological level of the whole animal.Keywords
This publication has 27 references indexed in Scilit:
- The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibitionAmerican Journal of Physiology-Cell Physiology, 2007
- Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activityProceedings of the National Academy of Sciences, 2006
- Erythroid-specific 5-aminolevulinate synthase protein is stabilized by low oxygen and proteasomal inhibitionBiochemistry and Cell Biology, 2005
- Erythropoietin receptors: their role beyond erythropoiesisNephrology Dialysis Transplantation, 2005
- Acclimatization to 4100 m does not change capillary density or mRNA expression of potential angiogenesis regulatory factors in human skeletal muscleJournal of Experimental Biology, 2004
- Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia‐reperfusion injuryThe FASEB Journal, 2004
- HIF hydroxylation and cellular oxygen sensingBiological Chemistry, 2004
- Activation of the Prolyl Hydroxylase Oxygen-sensor Results in Induction of GLUT1, Heme Oxygenase-1, and Nitric-oxide Synthase Proteins and Confers Protection from Metabolic Inhibition to CardiomyocytesJournal of Biological Chemistry, 2003
- Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analog N-oxaloglycine and its derivativesJournal of Medicinal Chemistry, 1992
- Survival under hypoxia. Age dependence and effect of cholinergic drugs.Stroke, 1980